Trends, drivers and alerts — the full picture.
A meaningful slice of reported profit is not turning into cash.
Its valuation sits in the cheaper end of its own recent range.
Revenue is growing at a steady pace.
Elevated leverage worth keeping an eye on.
More coming: dilution / share-count creep.
A cash-flow (DCF) estimate cross-checked against peer multiples.
Phibro Animal Health Corporation - Class A Common Stock turns 69¢ of every reported profit-dollar into real cash. A meaningful slice of reported profit is not turning into cash. Revenue is growing at a steady pace. Its valuation sits in the cheaper end of its own recent range. Elevated leverage worth keeping an eye on.
Signals and key numbers are from the fiscal Q3 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.